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In the mouse, opening of the vaginal cavity to the skin is a late event, occurring around the ®fth week of life; it can be
induced in sexually immature mice by b-estradiol injections. We have generated two lines of transgenic mice expressing
the human Bcl2 protein in a variety of tissues. The vaginal cavity of the transgenic females remained permanently closed,
a condition completely resistant to b-estradiol injections; this was accompanied by a considerable distension of the genital
tract. Histologic studies of vaginal sections at the time of opening to the skin in normal mice showed, by the TUNEL
method which detects nuclei with fragmented DNA characteristic of apoptosis, that this event coincides with extensive
apoptosis in the lower part of the vaginal mucosa, a process prevented in the bcl2 transgenic mice, which express Bcl2 in
suprabasal epithelial cells and in subepithelial cells of the vaginal mucosa. In contrast, two lines of mice bearing a Bcl2
transgene placed under the control of a K10 keratin promoter, whose expression is restricted to the suprabasal layers of
the epidermis, had a normal phenotype. Eyelids' formation and opening of the external ear canals, which also occur after
birth in the mouse, were not altered in any of these transgenic lines; histological study of eye and ear sections at the time of
these events failed to detect apoptosis. In conclusion, the tissue remodeling required to complete maturation of the mouse female
genital tract at the time of puberty is an hormonally triggered apoptosis-dependent process. q 1997 Academic Press
INTRODUCTION and BclxL , and promoters of death such as Bax, Bad, Bak
and BclxS (Oltvai and Korsmeyer, 1994; Farrow et al., 1995;
Yang et al., 1995). Proteins directly involved in the execu-Apoptosis, or programmed cell death, is probably a very
tion of programmed cell death appear to belong to a classcommon way to eliminate unnecessary or undesirable cells
of cysteine proteases with a speci®city of cleavage restrictedin the development of higher metazoa. It takes place even
to aspartic acid residues (Martin and Green, 1995). It hasin organisms with a limited number of cells; in Caenorhab-
been proposed that programmed cell death represents theditis elegans, for instance, identi®cation of the genes whose
normal fate of all cells, from which they are rescued bymutations prevent apoptosis and thus normal development
the existence of survival factors which are represented byhas shed considerable light on the molecular basis of this
signals given to the cells by a large variety of molecules,process (Ellis and Horvitz, 1991; Hengartner and Horvitz,
such as hormones, growth factors, cytokines, and cell mem-1994; Yuan et al., 1993). A family of proteins regulating
brane receptors involved in intercellular contact or cell±programmed cell death has now been identi®ed and is best
extracellular matrix interaction (Raff, 1992). Programmedknown in the mouse, with inhibitors of death such as Bcl2
cell death appears to represent a physiological way to modu-
late normal tissue development, since, in contrast to cell
damage in¯icted to cells by outside agents, which results1 Present address: Laboratory of Vertebrate Developmental Neu-
in cell necrosis, it is characterized by the absence of subse-rogenetics, The Rockefeller University, 1230 York Avenue, New
quent in¯ammatory reaction. Programmed cell death is alsoYork, NY 10021-6399.
characterized by the very rapid elimination of the remnants2 To whom correspondence should be addressed. Fax: //41 22
7025746. E-mail: Pierre.Vassalli@medecine.unige.ch. of apoptotic cells (or ``apoptotic bodies'') through ingestion
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and ®nal degradation by the surrounding surviving cells, Histological Examination, in Situ DNA Labeling on
Tissue Sections, and Immunohistochemistrywithout requiring the attraction of professional phagocytic
cells such as macrophages (White, 1993).
Tissues were ®xed in vivo with 4% paraformaldehyde in PBSEmbryogenesis is characterized by numerous tissue re- and embedded in paraf®n, and 5-mm sections were stained with
modelings, some of which are known to involve cell death hematoxylin and eosin. For detection of DNA fragmentation charac-
(Saunders, 1966), such as interdigital tissue regression, teristic of apoptotic nuclei, a modi®ed protocol of the TUNEL tech-
palate fusion, or formation of the central nervous system nique (Gavrieli et al., 1992) was used. Sections were deparaf®nized
(Raff et al., 1993; Zakeri et al., 1994; Mori et al., 1994). in xylol and treated for 15 min with 3 mg/ml proteinase K, followed
by 5 min in 2% H2O2, and the tailing reaction was then carried outPrevention of cell death by tissue overexpression of the Bcl2
in the TdT buffer (0.5% bovine serum albumin (BSA)) for 1 hr atprotein in mice bearing a bcl2 transgene has been taken as
377C. For immunohistochemistry, 5-mm deparaf®nized sectionsan indication that this process results from apoptosis, and
were rehydrated in ethanol and treated with methanol±H2O2 5%.used to explore the importance of apoptosis in tissue remod-
Slides were then rinsed in distilled water, plunged in 10 mM citrateeling before or after birth. This has been applied so far to
buffer, pH 6, and heated three times for 5 min in a microwave oven.the lymphoid (Sentman et al., 1991; Strasser et al., 1991)
Slides were washed with distilled water and incubated for 15 min
and nervous tissues (Martinou et al., 1994). In the mouse, in phosphate-buffered saline with 5% BSA. An anti-human Bcl2
some de®nitive tissue remodelings, such as those leading mouse monoclonal antibody (Dako A/S, Glostrup, Denmark) was
to the opening of the eyes, the ears, and of the vaginal cavity, added (1:20 dilution) for 1 hr at room temperature. After washing,
occur only after birth (Theiler, 1989). We describe here the an anti-mouse biotinylated antibody (Dako) was used at a 1:250
dilution for 30 min at room temperature. Biotin was revealed withapoptotic nature of the vaginal opening and its prevention
a streptavidin±peroxidase complex at a 1:100 dilution (Dako).in transgenic mice by the overexpression of the Bcl2 protein.
In contrast, we could not ®nd evidence for a comparable
local cutaneous apoptotic process at the time of eye or ear
Estradiol Injectionsopenings, which were not altered in these transgenic mice.
17b-Estradiol (Sigma Chemical Co. St. Louis, MO) was dissolved
in isopropanol. Fifteen micrograms of 17b-estradiol diluted in ¯ax
oil was injected intraperitoneally into 12-day-old female mice, andMATERIALS AND METHODS the injections were repeated daily for 5 days.
Mice
RESULTSA pgk±bcl2 construct was generated by insertion of a 900-bp
cDNA containing the human bcl2 coding sequence excised with
Vaginal Opening Does Not Occur in Bcl2EcoRI from pB4 (Tsujimoto and Croce, 1986, gift of Dr. Y. Tsuji-
moto), into pEMBLpgkSV (gift of Melanie Price, Dept. of Pathology, Transgenic Mice Showing Expression of the Bcl2
Geneva) previously digested with EcoRI. A DNA fragment con- Transgenic Protein in the Vaginal Mucosa
taining the mouse phosphoglycerate kinase 1 (PGK-1) promoter
Several mice bearing a pgk±bcl2 transgene (Fig. 1) werefollowed by the human bcl2 coding sequence, the intron and the
born normally and grew for a few weeks without any obvi-polyadenylation signal of the SV40T gene, was excised by digesting
the plasmid with S®I, isolated on agarose gel, and puri®ed on NACS ous phenotype. One of these mice exhibited a progressive
columns (Gibco BRL, Gaithersburg, MD). A K10-bcl2 transgene swelling of the genital region, becoming prominent at about
was generated by inserting the 900-bp hbcl2 fragment used for the 3 months of age (Fig. 2a); it had no testes and no open vagina.
pgk±bcl2 transgene into the EcoRI site of a plasmid previously At the opening of the peritoneal cavity, a massively dis-
generated by inserting a 1182-bp BamHI/PvuII fragment containing tended female genital tract was observed (Fig. 2b). To ensure
an intron and the polyadenylation signal of the rabbit b1-globin progeny to this mouse, its ovaries, whose gross appearance
gene into a pBluescript SK0 (Stratagene GMBH, Heidelberg) linear-
was normal, were transplanted into a normal (C57BL/6 1ized with BamHI and XhoI. This plasmid was linearized with NotI
DBA2)F1 female mouse of the same age, whose own ovariesand blunted, and the K10 bovine promoter, excised from pUCK10
had been partially resected. All transgenic progeny born(kind gift of J. L. Jorcano, Madrid) (Bailleul et al., 1990, Blessing et
from the transplanted ovaries had a comparable phenotype,al., 1989) with EcoRI and BglI and then blunted, was inserted. The
resulting transgene was excised by BssHII digestion. Transgenic characterized by lack of vaginal opening in females, and
mice were generated as described (Hogan et al., 1986). The T56 sterility in males (resulting from testicular abnormalities
PGK±bcl2 transgenic line was maintained by ovarian transplanta- (Rodriguez et al., 1997). Thus, this pgk±bcl2 transgenic line,
tion into (C57BL/6 1 DBA2)F1 mice, whose own ovaries had been T56, could be maintained only by ovary transplantation.
partially resected, since vaginal opening failed to occur and since An identical phenotype was found in another transgenic
transgenic males are sterile (Rodriguez et al., 1997). The generation line (T73 NSE±bcl2) in which the human bcl2 cDNA had
of transgenic lines of mice bearing a human bcl2 transgene placed
been placed under the control of a NSE promoter (Forssunder the control of a rat neuron-speci®c enolase (NSE) promoter
et al., 1990), which is, when used as a transgene, mainlyhas been described elsewhere (Martinou et al., 1994). All transgenic
expressed in neurons: lack of vaginal opening in femalesmice were bred on a C57BL/6 background. Nontransgenic lit-
was accompanied by identical gross and histologic appear-termate or normal C57BL/6 mice were used as controls. All mice
were purchased from IFFA CREDO (Lyon, France). ances of the female genital tract. Other NSE±bcl2 trans-
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mice, starting on the 12th day of age. This treatment is
known to induce precocious female sexual maturation, in-
cluding vaginal opening on Day 17. While vaginal opening
occurred at the expected time in all controls, all transgenic
mice were resistant to this treatment (compare Figs. 2c and
2d). Immunohistochemical analysis of sections of these
closed (transgenic mice) or open (normal mice) vaginas
showed that, in the T73 NSE±bcl2 transgenic mice, al-
though the NSE promoter is considered to be neuron-spe-
ci®c, the human Bcl2 protein was detectable within cells
of the vaginal epithelium (to the exception of the basal lay-
ers) and also within some submucosal cells, probably, at
least in part, ®broblasts (Fig. 2e). The localization of expres-
sion of the transgene in the T56 pgk±bcl2 animals was very
similar and the expression was also poor in the basal layers
of the vaginal epithelium (data not shown). No histological
difference between the vaginas of control and pgk±bcl2 or
NSE±bcl2 transgenic animals could be detected in imma-
ture animals not treated with hormones, thus excluding a
possible effect of the transgene on the rate or the duration
of proliferation of the cells during vaginal formation. The
other lines generated with the two transgenes and which
FIG. 1. PGK±bcl2, NSE ±bcl2, and K10±bcl2 constructs. A mouse had normal vaginal opening did not express human Bcl2 in
phosphoglycerate kinase 1, a rat NSE, and a bovine K10 promoter the vaginal mucosa. Speci®city of the staining for human
were used for the constructs; the complete coding sequence of a Bcl2 was ascertained by its absence in the vagina of normal
human bcl2 cDNA, followed by the intron and the polyadenylation mice (Fig. 2f). Attempts at detecting endogenous mouse Bcl2
site of the SV40 T gene were placed downstream for the PGK±bcl2 protein around the time of vaginal opening did not show
and NSE±bcl2 transgenes. A rabbit b-globin intron and polyadenyl-
any conclusive staining in transgenic nor in normal mice.ation signal were used for the K10±bcl2 transgene.
Ear and eye openings occurred at the same time in
transgenic mice and their negative littermates, i.e., within
3 days after birth for ears and on Days 12 to 14 for eye
genic lines lacked this phenotype. Both the T56 pgk±bcl2 openings. Staining for human Bcl2 showed only a faint ex-
and T73 NSE±bcl2 transgenic lines expressed the human pression in skins of the T56 pgk±bcl2 transgenic mice in
Bcl2 protein in the brain, and their brain and neuronal fea- these locations and no detectable expression in the T72
tures have been reported elsewhere (Martinou et al., 1994). NSE±bcl2 line (not shown).
Finally, two K10±bcl2 transgenic lines were also obtained.Analysis of a number of other tissues of the pgk±bcl2
The keratin K10 promoter is active only in the suprabasaltransgenic mice by Northern and Western blots showed that
layer of the epidermis (Bailleul et al., 1990). Expression ofthe human bcl2 mRNA and protein were expressed in the
the transgene in the skin of these two lines was detected byliver (Rodriguez et al., 1996), testis (Rodriguez et al., 1997),
RT±PCR. These lines had a normal phenotype, and vaginaland at variable levels, sometimes very weak, in the kidneys,
opening was not delayed in comparison with nontransgenicgut, spleen, and epidermis; all these tissues, with the excep-
female littermates. In order to evaluate the functionality oftion of the testes and of the brain, appeared grossly and
the transgene, one of these lines was used for crossing with ahistologically normal, and no particular incidence of
K10-myc transgenic line. Double transgenic mice, expressinglymphomas was observed. Expression of the transgene in
both Myc and Bcl2 in the epidermal suprabasal layers, devel-embryos was not explored. It should be noted that transgene
oped permanent skin papillomas after repeated topical expo-expression might have been high, leading to lethality, in
sure to phorbol myristic acetate, in contrast to singlesome embryos bearing a pgk±bcl2 transgene since the ratio
transgenic K10-myc mice (I.R. and P.V., unpublished experi-of transgenic mice was markedly lower than expected after
ments); this showed that expression of the K10±bcl2injection of oocyte with the pgk±bcl2 construct.
transgene was effective. However, immunohistochemistry
Lack of vaginal opening in these transgenic mice persisted and RT±PCR analysis being insuf®ciently quantitative, it
until their death, and was accompanied by genital swelling was not possible to compare in a precise manner the levels
(Fig. 2a) resulting from a strongly distended genital tract of Bcl2 epidermal expression between the pgk±bcl2 mice
(Fig. 2b), probably due to the accumulation of uterine and with a lack of vaginal opening and the K10±bcl2 mice with
oviductal secretions and slough vaginal epithelial cells. a normal phenotype (see discussion).
Since vaginal opening is an hormone-dependent process, a
Detection of Local Tissue Apoptosis at the Time oflack of appropriate estrogen expression in ovaries at the
Vaginal Openingtime of sexual maturation might result in a closed vagina
phenotype. To explore this possibility, b-estradiol was in- To evaluate whether vaginal opening was the result of
cell death by apoptosis in the septum covering the lowerjected for 5 consecutive days into 6 control and 4 transgenic
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FIG. 2. (a) A 3-month-old pgk±bcl2 transgenic female mouse. Note the swelling of the genital region. (b) Female genital tract of a control
mouse (left) and of a pgk±bcl2 transgenic female mouse, at 3.5 months of age. (c, d) Histologic sections of the lower extremity of the
vagina in a 17-day-old T72 NSE±Bcl2 transgenic (c) and control (d) mouse, respectively, 5 days after 17b-estradiol injection. Opening of
the vagina occurred in the control mouse (d) and failed to occur in the transgenic mouse (c), in which the arrow points to the region of
the expected vaginal aperture. (e) Expression of the human Bcl2 protein in the transgenic T73 NSE±bcl2 female genital tract of a 17-day-
old mouse treated with 17b-estradiol (see c), as detected by immunohistochemistry (brown color). Bcl2 is detected within the upper layers
of the vaginal epidermis and in submucosal cells, probably ®broblasts. The localization of expression of the human Bcl2 protein is
comparable in estradiol-treated and nontreated transgenic animals. (f) Control immunohistochemical staining for human Bcl2 in the
genital tract with vaginal opening of a 17-day-old normal mouse treated with b-estradiol (see d). No speci®c staining is detected.
extremity of the vagina, serial sections of the genital tracts before vaginal opening. In contrast, large number of labeled
cells were observed in the regressing tissue at the very timewere performed on 4.5- to 7-week-old normal mice, and
examined by the TUNEL method, which detects the high of vaginal opening, as shown in Fig. 3b in which an ``apop-
totic plug,'' consisting in an aggregate of hundreds of apop-level of nuclear DNA fragmentation characteristic of apop-
totic nuclei. No or very rare apoptotic cells were detected totic cells, is seen. Localization of these apoptotic cells was
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8522 / 6x1f$$$$21 03-20-97 21:09:51 dbal
119Apoptosis during Vaginal Opening
FIG. 3. Histologic sections of various tissues stained with the TUNEL method. Nuclei displaying DNA fragmentation are stained in
brown. (a) Apoptotic cells 3 hr after vaginal opening in a 5-week-old mouse (2001). For a and b the inside of the genital tract is on the
left. (b) Apoptotic ``plug'' during the vaginal opening of a 5-week-old female mouse (4001). (c) Histologic section at the level of lids
formation in a 2-week-old C57BL/6 male mouse (8001). No labeled cells can be found. The picture represents the lower lid at the time
of its separation with the upper lid. (d) Histologic section taken at the time of the opening of the external auditive canal in a 2-day-old
C57BL/6 male mouse (8001). No labeled cells can be found.
topographically precisely limited to the area of vaginal DISCUSSION
opening; except for areas where the extent of apoptosis
made identi®cation of the origin of the apoptotic cells im- The detection, at the time of vaginal opening, of extensive
possible, apoptosis of epithelial cells could be clearly identi- apoptosis in the lower end of the vagina and in the septum
®ed, although it was probably not restricted to epithelium. closing the vaginal cavity, combined with the failure of two
This apoptotic process was not only massive but also re- distinct bcl2 transgenic mouse lines expressing the
stricted in time, since we were not able to observe it at its transgene in this very location to display vaginal opening,
very beginning, i.e., with only sparse apoptotic cells, and even after hormonal induction, provides compelling evi-
since a few hours after vaginal opening only few cells la- dence that this postnatal tissue remodeling event rests upon
beled by TUNEL were detected (Fig. 3a), which had com- an hormonally triggered process of apoptosis. This process
pletely disappeared on the following day. appears to be very restricted not only in its site, but also in
Serial sections of the genital tracts were also performed its duration, and has probably virtually ceased a few hours
on 4.5- to 7-week-old pgk±bcl2 transgenic animals; no or after vaginal opening. It affects mostly the suprabasal layers
very rare apoptotic cells could be observed in the sections, of the vaginal epithelium, but also some submucosal cells,
thus demonstrating the effect of Bcl2 expression on probably ®broblasts. Prevention of vaginal opening in the
apoptosis. pgk±bcl2 transgenic mice might result from the expression
Serial sections of the ears and eyes were performed at the of Bcl2 in both subepithelial and epithelial cells (Fig. 2e).
time of ear septum and eyelids openings, respectively. In The K10±bcl2 transgenic mice, in which use of the keratin
contrast to what was observed for the vaginal tract, no sig- K10 promoter restricted transgene expression to the su-
ni®cant presence of cells labeled by the TUNEL technique prabasal layers of the epidermis, were phenotypically nor-
mal. Thus, it appears that the initiating apoptotic events inwas detected. (Figs. 3c and 3d).
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vaginal opening may not be those involving the epithelium, nal opening (Knudson et al., 1995). A drop in the BclxL
protein, whose antiapoptotic property is very comparableor at least are not restricted to the epithelium. However,
since a precise comparison of Bcl2 expression levels in su- to that of Bcl2 but is more indispensable in fetal life, since
bclx 0/0 embryos die in utero (Motoyama et al., 1995), orprabasal epithelial cells between the different bcl2
transgenic lines was not possible, the exact place of epithe- an increased expression of the Bclxs protein, remain distinct
possibilities as a mechanism leading to this localizedlial cell apoptosis in the chain of events leading to vaginal
opening remains to be determined. apoptosis. Detection of local variations at the time of vagi-
nal opening in the mRNA and protein levels of BclxL orIt should be emphasized that there is no established rela-
tionship between the level of expression of a bcl2 transgene Bclxs and also of Bak, Bax, and Bad, all involved in the
control of programmed cell death, is presently under study.in a given tissue and its effect on the development of this
tissue or even its resistance to apoptosis. Thus, in the pgk± It must be indeed realized that the intracellular levels of at
least some of these apoptosis-related proteins has beenbcl2 mice, the highest expression of Bcl2 was observed in
the brain and the testes (which both showed abnormal de- shown in some conditions to be regulated by external sig-
nals received by the cells, among which sexual hormonesvelopment: Martinou et al., 1994, Rodriguez et al., 1997),
and in the liver (which is structurally normal: Rodriguez et (Tilly et al., 1995).
Two other remodeling events involving mucosae also oc-al., 1996), while Bcl2 expression at the vaginal area of open-
ing was apparently weaker, as judged by immunohisto- cur after birth in the mouse, i.e., opening of the ear conducts
and formation of the palpebral slits. They were not alteredchemistry. Furthermore, we have observed that in some
tissues considered to undergo permanent and extensive in these bcl2 transgenic mice, but this may have resulted
from insuf®cient expression of the transgene in these loca-apoptosis in relation with cell renewal, such as the small
intestine, even a very high expression of transgenic Bcl2 in tions. However, the failure to detect any evidence of
apoptosis by the TUNEL technique on tissue sections ob-enterocytes (obtained in mice bearing a bcl2 transgene
placed under the control of the intestinal fatty acid-binding tained from the ear and eye regions at the time of occurrence
of epidermis remodeling suggests that massive cell death isprotein promoter: Sweetser et al., 1988) does not lead to
tissue changes, nor protects enterocytes in vivo or in vitro not involved in these events, or that cell elimination occurs
through mechanisms distinct from these identi®ed underagainst apoptotic stimuli (I.R. and P.V., unpublished obser-
vations). It can be concluded that if a developmental event the name of apoptosis.
shows both involvement of apoptosis and prevention by
forced expression of Bcl2, even weakly, this association
shows conclusively that this event is mediated by an apop- ACKNOWLEDGMENTS
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